Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Intra-arterial chemoinfusion prior to chemoradiotherapy with full-dose systemic gemcitabine for management of locally advanced pancreatic cancer.

Tanaka T, Nishiofuku H, Tamamoto T, Sho M, Anai H, Sueyoshi S, Sakaguchi H, Hasegawa M, Nakajima Y, Kichikawa K.

Anticancer Res. 2011 Nov;31(11):3909-12.

PMID:
22110218
2.

[Locally advanced pancreatic cancer successfully treated by arterial infusion chemotherapy combined with stereotactic radiotherapy--a case report].

Nishiofuku H, Tanaka T, Anai H, Sueyoshi S, Yamamoto K, Morimoto K, Maeda S, Masada T, Sho M, Nakajima Y, Tamamoto T, Hasegawa M, Sakaguchi H, Kichikawa K.

Gan To Kagaku Ryoho. 2010 Nov;37(12):2315-8. Japanese.

PMID:
21224558
3.

Neoadjuvant gemcitabine-based accelerated hyperfractionation chemoradiotherapy for patients with borderline resectable pancreatic adenocarcinoma.

Takeda Y, Nakamori S, Eguchi H, Kobayashi S, Marubashi S, Tanemura M, Konishi K, Yoshioka Y, Umeshita K, Mori M, Doki Y, Nagano H.

Jpn J Clin Oncol. 2014 Dec;44(12):1172-80. doi: 10.1093/jjco/hyu143. Epub 2014 Oct 1.

PMID:
25425728
4.

Unresectable pancreatic cancer: arterial embolization to achieve a single blood supply for intraarterial infusion of 5-fluorouracil and full-dose IV gemcitabine.

Tanaka T, Sho M, Nishiofuku H, Sakaguchi H, Inaba Y, Nakajima Y, Kichikawa K.

AJR Am J Roentgenol. 2012 Jun;198(6):1445-52. doi: 10.2214/AJR.11.8008. Erratum in: AJR Am J Roentgenol. 2012 Aug;199(2):471.

PMID:
22623561
5.

Impact of gemcitabine chemotherapy and 3-dimensional conformal radiation therapy/5-fluorouracil on quality of life of patients managed for pancreatic cancer.

Short M, Goldstein D, Halkett G, Reece W, Borg M, Zissiadis Y, Kneebone A, Spry N.

Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):157-62. doi: 10.1016/j.ijrobp.2012.03.003. Epub 2012 Apr 28.

PMID:
22543205
6.

Phase II study of gemcitabine chemotherapy alone for locally advanced pancreatic carcinoma: JCOG0506.

Ishii H, Furuse J, Boku N, Okusaka T, Ikeda M, Ohkawa S, Fukutomi A, Hamamoto Y, Nakamura K, Fukuda H; JCOG Gastrointestinal Oncology Study Group.

Jpn J Clin Oncol. 2010 Jun;40(6):573-9. doi: 10.1093/jjco/hyq011. Epub 2010 Feb 25.

PMID:
20185458
7.

5-fluorouracil intra-arterial infusion combined with systemic gemcitabine for unresectable pancreatic cancer.

Takamori H, Kanemitsu K, Tsuji T, Tanaka H, Chikamoto A, Nakahara O, Hiraoka T, Ikeda O, Kudo K, Imuta M, Yamashita Y.

Pancreas. 2005 Apr;30(3):223-6.

PMID:
15782098
8.

Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?

Crane CH, Abbruzzese JL, Evans DB, Wolff RA, Ballo MT, Delclos M, Milas L, Mason K, Charnsangavej C, Pisters PW, Lee JE, Lenzi R, Vauthey JN, Wong AB, Phan T, Nguyen Q, Janjan NA.

Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1293-302.

PMID:
11955742
9.

Adjuvant intra-arterial 5-fluoruracil, leucovorin, epirubicin and carboplatin with or without systemic gemcitabine after curative resection for pancreatic adenocarcinoma.

Cantore M, Serio G, Pederzoli P, Mambrini A, Iacono C, Pulica C, Capelli P, Lombardi M, Torri T, Pacetti P, Pagani M, Fiorentini G.

Cancer Chemother Pharmacol. 2006 Oct;58(4):504-8. Epub 2006 Apr 22.

PMID:
16633830
10.

Feasibility and efficacy of combination therapy with preoperative full-dose gemcitabine, concurrent three-dimensional conformal radiation, surgery, and postoperative liver perfusion chemotherapy for T3-pancreatic cancer.

Ohigashi H, Ishikawa O, Eguchi H, Takahashi H, Gotoh K, Yamada T, Yano M, Nakaizumi A, Uehara H, Tomita Y, Nishiyama K.

Ann Surg. 2009 Jul;250(1):88-95. doi: 10.1097/SLA.0b013e3181ad65cc.

PMID:
19561477
11.

Hypofractionated Conformal Radiotherapy with Concurrent Full-Dose Gemcitabine Versus Standard Fractionation Radiotherapy with Concurrent Fluorouracil for Unresectable Pancreatic Cancer: a Multi-Institution Experience.

Rakhra S, Strauss JB, Robertson J, McGinn CJ, Kim T, Huang J, Blake A, Helenowski I, Hayes JP, Mulcahy M, Small W Jr.

J Gastrointest Cancer. 2016 Jun;47(2):196-201. doi: 10.1007/s12029-016-9821-9.

PMID:
27112332
12.

Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma.

Wolff RA, Evans DB, Gravel DM, Lenzi R, Pisters PW, Lee JE, Janjan NA, Charnsangavej C, Abbruzzese JL.

Clin Cancer Res. 2001 Aug;7(8):2246-53.

13.

Gemcitabine chemotherapy versus 5-fluorouracil-based concurrent chemoradiotherapy in locally advanced unresectable pancreatic cancer.

Park JK, Ryu JK, Lee JK, Yoon WJ, Lee SH, Kim YT, Yoon YB.

Pancreas. 2006 Nov;33(4):397-402.

PMID:
17079946
14.

Long-term results of full-dose gemcitabine with radiation therapy compared to 5-fluorouracil with radiation therapy for locally advanced pancreas cancer.

Huang J, Robertson JM, Margolis J, Balaraman S, Gustafson G, Khilanani P, Nadeau L, Jury R, McIntosh B.

Radiother Oncol. 2011 May;99(2):114-9. doi: 10.1016/j.radonc.2011.05.038. Epub 2011 May 27.

PMID:
21621866
15.

[Locally advanced unresectable pancreatic cancer: Induction chemoradiotherapy followed by maintenance gemcitabine versus gemcitabine alone: Definitive results of the 2000-2001 FFCD/SFRO phase III trial].

Barhoumi M, Mornex F, Bonnetain F, Rougier P, Mariette C, Bouché O, Bosset JF, Aparicio T, Mineur L, Azzedine A, Hammel P, Butel J, Stremsdoerfer N, Maingon P, Bedenne L, Chauffert B.

Cancer Radiother. 2011 Jun;15(3):182-91. doi: 10.1016/j.canrad.2010.10.001. Epub 2011 Feb 10. French.

PMID:
21315644
16.

Chemoradiotherapy with twice-weekly administration of low-dose gemcitabine for locally advanced pancreatic cancer.

Igarashi H, Ito T, Kawabe K, Hisano T, Arita Y, Kaku T, Takayanagi R.

World J Gastroenterol. 2008 Sep 14;14(34):5311-5.

17.

Survival after chemoradiation in resected pancreatic cancer: the impact of adjuvant gemcitabine.

Baschnagel A, Shah C, Margolis J, Nadeau L, Stein J, Jury R, Robertson JM.

Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):e331-5. doi: 10.1016/j.ijrobp.2012.01.008. Epub 2012 Mar 13.

PMID:
22420967
18.

Adjuvant PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) or gemcitabine followed by chemoradiation in pancreatic cancer: a randomized phase II trial.

Reni M, Balzano G, Aprile G, Cereda S, Passoni P, Zerbi A, Tronconi MC, Milandri C, Saletti P, Rognone A, Fugazza C, Magli A, Di Muzio N, Di Carlo V, Villa E.

Ann Surg Oncol. 2012 Jul;19(7):2256-63. doi: 10.1245/s10434-011-2205-2. Epub 2012 Jan 12.

PMID:
22237835
19.

Intra-arterial continuous infusion for treatment of pancreatic and biliary tract cancer.

Zanon C, Alabiso O, Grosso M, Buosi R, Chiappino I, Clara R, Satolli A, Zai S, Bortolini M, Botta M, Mussa A.

Int J Pancreatol. 2000 Jun;27(3):225-33.

PMID:
10952405
20.

Chemoradiotherapy with gemcitabine and continuous 5-FU in patients with primary inoperable pancreatic cancer.

Wilkowski R, Thoma M, Bruns C, Wagner A, Heinemann V.

JOP. 2006 Jul 10;7(4):349-60.

Supplemental Content

Support Center